| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prolactin | 33 | 2007 | 142 | 3.380 |
Why?
|
| Prostatic Neoplasms | 34 | 2022 | 1416 | 2.710 |
Why?
|
| Mitosis | 9 | 2016 | 191 | 2.040 |
Why?
|
| Phosphoproteins | 24 | 2017 | 447 | 1.900 |
Why?
|
| Cell Cycle Proteins | 13 | 2016 | 708 | 1.810 |
Why?
|
| Bone Neoplasms | 18 | 2022 | 474 | 1.780 |
Why?
|
| Osteoblasts | 14 | 2022 | 175 | 1.500 |
Why?
|
| DNA-Binding Proteins | 30 | 2013 | 1936 | 1.480 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2019 | 124 | 1.170 |
Why?
|
| Nuclear Proteins | 12 | 2016 | 1210 | 1.130 |
Why?
|
| Trans-Activators | 18 | 2005 | 695 | 1.100 |
Why?
|
| Receptors, Prolactin | 13 | 2002 | 24 | 0.970 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2016 | 597 | 0.960 |
Why?
|
| Milk Proteins | 10 | 2002 | 95 | 0.790 |
Why?
|
| Signal Transduction | 27 | 2019 | 4663 | 0.790 |
Why?
|
| Proteins | 10 | 2017 | 1006 | 0.780 |
Why?
|
| Culture Media, Conditioned | 5 | 2019 | 81 | 0.710 |
Why?
|
| Neoplasm Proteins | 8 | 2018 | 679 | 0.670 |
Why?
|
| Interferon Regulatory Factor-1 | 23 | 2005 | 38 | 0.650 |
Why?
|
| Transcription, Genetic | 16 | 2014 | 1362 | 0.640 |
Why?
|
| Bone Morphogenetic Protein 1 | 1 | 2019 | 2 | 0.620 |
Why?
|
| Kinetochores | 3 | 2012 | 7 | 0.610 |
Why?
|
| Fungal Proteins | 6 | 2003 | 136 | 0.610 |
Why?
|
| Cell Movement | 14 | 2021 | 875 | 0.600 |
Why?
|
| Gene Expression Regulation | 17 | 2003 | 2319 | 0.580 |
Why?
|
| Aurora Kinase B | 2 | 2016 | 12 | 0.570 |
Why?
|
| Cytokinesis | 2 | 2016 | 23 | 0.560 |
Why?
|
| Cell Line, Tumor | 21 | 2021 | 3733 | 0.550 |
Why?
|
| Promoter Regions, Genetic | 16 | 2010 | 1207 | 0.540 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2009 | 248 | 0.530 |
Why?
|
| Proteoglycans | 1 | 2018 | 77 | 0.530 |
Why?
|
| Cadherins | 7 | 2017 | 182 | 0.530 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2018 | 111 | 0.520 |
Why?
|
| Histone Deacetylases | 4 | 2013 | 130 | 0.510 |
Why?
|
| T-Lymphocytes | 12 | 2001 | 1715 | 0.500 |
Why?
|
| Microtubules | 5 | 2012 | 132 | 0.490 |
Why?
|
| Animals | 80 | 2021 | 33725 | 0.480 |
Why?
|
| HeLa Cells | 8 | 2016 | 688 | 0.460 |
Why?
|
| Acetylation | 6 | 2013 | 191 | 0.450 |
Why?
|
| Androgens | 3 | 2012 | 246 | 0.440 |
Why?
|
| Dyneins | 3 | 2004 | 15 | 0.420 |
Why?
|
| Endothelial Cells | 5 | 2022 | 520 | 0.420 |
Why?
|
| Rats | 25 | 2007 | 3368 | 0.410 |
Why?
|
| Tumor Cells, Cultured | 20 | 2017 | 974 | 0.410 |
Why?
|
| Transfection | 17 | 2017 | 961 | 0.400 |
Why?
|
| Transcription Factors | 18 | 2021 | 2402 | 0.400 |
Why?
|
| Cell Proliferation | 10 | 2018 | 2460 | 0.380 |
Why?
|
| Spindle Apparatus | 2 | 2013 | 49 | 0.370 |
Why?
|
| Chromosomes | 2 | 2010 | 120 | 0.370 |
Why?
|
| Phosphorylation | 15 | 2016 | 1570 | 0.360 |
Why?
|
| Neoplasm Metastasis | 9 | 2021 | 713 | 0.360 |
Why?
|
| Up-Regulation | 4 | 2012 | 826 | 0.350 |
Why?
|
| Down-Regulation | 5 | 2010 | 645 | 0.350 |
Why?
|
| Bone Marrow | 5 | 2021 | 317 | 0.350 |
Why?
|
| Bone and Bones | 5 | 2018 | 307 | 0.350 |
Why?
|
| Transcriptional Activation | 4 | 2001 | 419 | 0.350 |
Why?
|
| Receptor, ErbB-3 | 6 | 2008 | 24 | 0.340 |
Why?
|
| Cell Nucleus | 8 | 2007 | 556 | 0.340 |
Why?
|
| Cell Differentiation | 10 | 2018 | 1918 | 0.330 |
Why?
|
| Cell Division | 10 | 2004 | 718 | 0.320 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2010 | 67 | 0.320 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2012 | 618 | 0.320 |
Why?
|
| Prometaphase | 1 | 2010 | 1 | 0.320 |
Why?
|
| Mice | 38 | 2021 | 18198 | 0.320 |
Why?
|
| Growth Hormone | 4 | 1999 | 130 | 0.310 |
Why?
|
| Molecular Sequence Data | 23 | 2014 | 3461 | 0.300 |
Why?
|
| Proteome | 1 | 2012 | 285 | 0.300 |
Why?
|
| Humans | 75 | 2022 | 130511 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2021 | 2024 | 0.290 |
Why?
|
| DNA | 13 | 2010 | 1397 | 0.290 |
Why?
|
| STAT1 Transcription Factor | 9 | 2005 | 80 | 0.280 |
Why?
|
| DNA Helicases | 1 | 2010 | 238 | 0.270 |
Why?
|
| S Phase | 4 | 2001 | 76 | 0.260 |
Why?
|
| Caseins | 6 | 1988 | 65 | 0.260 |
Why?
|
| Prostate | 3 | 2019 | 403 | 0.260 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2007 | 65 | 0.260 |
Why?
|
| p21-Activated Kinases | 1 | 2007 | 57 | 0.260 |
Why?
|
| RNA, Messenger | 17 | 2014 | 2544 | 0.250 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2007 | 101 | 0.250 |
Why?
|
| ras Proteins | 1 | 2007 | 140 | 0.250 |
Why?
|
| Base Sequence | 22 | 2008 | 2727 | 0.250 |
Why?
|
| Metaphase | 1 | 2006 | 32 | 0.250 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 618 | 0.240 |
Why?
|
| Protein Binding | 8 | 2015 | 1651 | 0.240 |
Why?
|
| Cell Survival | 4 | 2018 | 825 | 0.240 |
Why?
|
| Tumor Microenvironment | 3 | 2021 | 710 | 0.230 |
Why?
|
| Cell Line | 14 | 2013 | 2552 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2017 | 288 | 0.230 |
Why?
|
| Membrane Proteins | 3 | 2019 | 1589 | 0.230 |
Why?
|
| COS Cells | 9 | 2003 | 253 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 170 | 0.220 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2017 | 484 | 0.220 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2017 | 113 | 0.220 |
Why?
|
| NF-kappa B | 3 | 2005 | 440 | 0.220 |
Why?
|
| Recombinant Proteins | 11 | 2011 | 1319 | 0.220 |
Why?
|
| Male | 38 | 2022 | 64586 | 0.210 |
Why?
|
| Immunoblotting | 3 | 2012 | 292 | 0.210 |
Why?
|
| G1 Phase | 4 | 2001 | 68 | 0.210 |
Why?
|
| Gene Expression | 7 | 2017 | 1482 | 0.210 |
Why?
|
| Amino Acid Sequence | 14 | 2014 | 2392 | 0.200 |
Why?
|
| Interferon-gamma | 5 | 2002 | 542 | 0.200 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 2 | 2001 | 11 | 0.200 |
Why?
|
| Ossification, Heterotopic | 2 | 2015 | 36 | 0.200 |
Why?
|
| Interphase | 2 | 2013 | 37 | 0.200 |
Why?
|
| Mice, SCID | 8 | 2018 | 585 | 0.190 |
Why?
|
| Microscopy, Fluorescence | 3 | 2012 | 303 | 0.190 |
Why?
|
| Bone Morphogenetic Protein 4 | 4 | 2021 | 41 | 0.190 |
Why?
|
| Cell Communication | 4 | 2017 | 187 | 0.190 |
Why?
|
| Neurons | 4 | 2009 | 1971 | 0.190 |
Why?
|
| Immunoprecipitation | 3 | 2014 | 189 | 0.190 |
Why?
|
| Nitric Oxide | 1 | 2005 | 465 | 0.180 |
Why?
|
| Stromal Cells | 4 | 2021 | 316 | 0.180 |
Why?
|
| STAT5 Transcription Factor | 8 | 2002 | 93 | 0.180 |
Why?
|
| Molecular Motor Proteins | 1 | 2001 | 29 | 0.180 |
Why?
|
| Tenascin | 1 | 2021 | 33 | 0.180 |
Why?
|
| Sp1 Transcription Factor | 1 | 2001 | 39 | 0.170 |
Why?
|
| Hormones | 3 | 1988 | 162 | 0.170 |
Why?
|
| Cells, Cultured | 11 | 2017 | 2882 | 0.170 |
Why?
|
| Protein Transport | 4 | 2013 | 366 | 0.170 |
Why?
|
| Peptides, Cyclic | 2 | 2012 | 46 | 0.170 |
Why?
|
| Trypsin | 2 | 2012 | 68 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2012 | 359 | 0.170 |
Why?
|
| Immunity | 1 | 2002 | 178 | 0.160 |
Why?
|
| Proteomics | 3 | 2017 | 616 | 0.160 |
Why?
|
| Models, Biological | 5 | 2010 | 1371 | 0.160 |
Why?
|
| Genes | 4 | 1990 | 308 | 0.150 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2021 | 105 | 0.150 |
Why?
|
| Peptide Fragments | 5 | 2005 | 686 | 0.150 |
Why?
|
| Adipocytes | 2 | 2021 | 178 | 0.150 |
Why?
|
| Adenosine Triphosphatases | 2 | 2011 | 189 | 0.150 |
Why?
|
| Blotting, Western | 7 | 2014 | 1013 | 0.150 |
Why?
|
| Adiposity | 1 | 2021 | 209 | 0.150 |
Why?
|
| Tubulin | 2 | 2010 | 75 | 0.150 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 1283 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 4 | 2013 | 978 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2014 | 219 | 0.140 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 254 | 0.140 |
Why?
|
| Disease Progression | 3 | 2021 | 2192 | 0.140 |
Why?
|
| Endothelium, Vascular | 4 | 2017 | 468 | 0.140 |
Why?
|
| Chromatin | 2 | 2001 | 499 | 0.140 |
Why?
|
| Prostatectomy | 1 | 2019 | 304 | 0.140 |
Why?
|
| Skull | 1 | 2019 | 148 | 0.140 |
Why?
|
| Acetyl Coenzyme A | 1 | 2018 | 18 | 0.140 |
Why?
|
| RNA Interference | 4 | 2017 | 491 | 0.140 |
Why?
|
| A549 Cells | 1 | 2018 | 47 | 0.140 |
Why?
|
| Lymphocytes | 3 | 2000 | 344 | 0.130 |
Why?
|
| Carcinogenesis | 2 | 2018 | 336 | 0.130 |
Why?
|
| Cell Adhesion | 5 | 2014 | 308 | 0.130 |
Why?
|
| Proline | 3 | 1996 | 79 | 0.130 |
Why?
|
| Calcification, Physiologic | 1 | 2017 | 24 | 0.130 |
Why?
|
| Golgi Apparatus | 1 | 1998 | 92 | 0.130 |
Why?
|
| Pregnancy Proteins | 3 | 2002 | 17 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 137 | 0.130 |
Why?
|
| Repressor Proteins | 2 | 2014 | 758 | 0.130 |
Why?
|
| Endotoxins | 1 | 2017 | 50 | 0.130 |
Why?
|
| Histones | 1 | 2001 | 541 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 158 | 0.130 |
Why?
|
| Precipitin Tests | 3 | 2001 | 109 | 0.130 |
Why?
|
| Receptors, LDL | 1 | 2017 | 106 | 0.120 |
Why?
|
| Exosomes | 1 | 2017 | 60 | 0.120 |
Why?
|
| Thymus Gland | 3 | 2000 | 104 | 0.120 |
Why?
|
| Interferon Type I | 3 | 2002 | 118 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2010 | 209 | 0.120 |
Why?
|
| Acute Lung Injury | 1 | 2017 | 68 | 0.120 |
Why?
|
| Protein Phosphatase 2 | 1 | 2016 | 34 | 0.120 |
Why?
|
| Cytokines | 4 | 2017 | 1332 | 0.120 |
Why?
|
| Immune System | 1 | 1997 | 99 | 0.120 |
Why?
|
| Chromosomal Instability | 1 | 2016 | 59 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 1996 | 81 | 0.120 |
Why?
|
| Binding Sites | 7 | 2002 | 1133 | 0.120 |
Why?
|
| Killer Cells, Natural | 1 | 1998 | 353 | 0.120 |
Why?
|
| Clathrin | 1 | 2015 | 21 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2016 | 198 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 1998 | 508 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2017 | 223 | 0.110 |
Why?
|
| Concanavalin A | 2 | 1992 | 15 | 0.110 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 662 | 0.110 |
Why?
|
| Endocytosis | 1 | 2015 | 121 | 0.110 |
Why?
|
| Lymphoma, T-Cell | 5 | 1997 | 60 | 0.110 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2014 | 7 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 450 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2007 | 108 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2014 | 48 | 0.110 |
Why?
|
| Receptors, Cytokine | 2 | 1996 | 65 | 0.110 |
Why?
|
| Proteolysis | 2 | 2014 | 201 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 744 | 0.110 |
Why?
|
| Genes, env | 1 | 1994 | 10 | 0.100 |
Why?
|
| Macrophages | 1 | 1998 | 664 | 0.100 |
Why?
|
| Thiazoles | 2 | 2010 | 113 | 0.100 |
Why?
|
| Ornithine Decarboxylase | 2 | 1994 | 19 | 0.100 |
Why?
|
| Tyrosine | 4 | 2002 | 142 | 0.100 |
Why?
|
| Inflammation | 1 | 2002 | 1481 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2000 | 150 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2017 | 1009 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2011 | 970 | 0.100 |
Why?
|
| Pyrimidines | 3 | 2017 | 448 | 0.100 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 358 | 0.100 |
Why?
|
| Neoplasm Transplantation | 3 | 2014 | 358 | 0.100 |
Why?
|
| Pneumonia | 1 | 2017 | 340 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2012 | 254 | 0.100 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2013 | 8 | 0.100 |
Why?
|
| cdc25 Phosphatases | 1 | 2013 | 19 | 0.100 |
Why?
|
| beta Catenin | 1 | 2014 | 197 | 0.100 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 420 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 37 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 258 | 0.100 |
Why?
|
| Subcellular Fractions | 2 | 2010 | 89 | 0.100 |
Why?
|
| Cloning, Molecular | 5 | 2001 | 780 | 0.100 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 1590 | 0.100 |
Why?
|
| Integrin beta1 | 1 | 2013 | 51 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2013 | 97 | 0.090 |
Why?
|
| Hydroxamic Acids | 2 | 2010 | 60 | 0.090 |
Why?
|
| Aurora Kinases | 1 | 2012 | 27 | 0.090 |
Why?
|
| Adenoviridae | 3 | 2004 | 578 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 1075 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2014 | 623 | 0.090 |
Why?
|
| Phenotype | 3 | 2017 | 4455 | 0.090 |
Why?
|
| Cell Extracts | 1 | 2012 | 14 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2017 | 994 | 0.090 |
Why?
|
| Necrosis | 1 | 2012 | 192 | 0.090 |
Why?
|
| Lymphatic System | 1 | 1991 | 18 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 4 | 2016 | 378 | 0.090 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 57 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2012 | 138 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 1205 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 1992 | 235 | 0.090 |
Why?
|
| Protein Kinases | 2 | 2003 | 312 | 0.090 |
Why?
|
| Osteonectin | 2 | 2010 | 7 | 0.090 |
Why?
|
| Mutation | 6 | 2016 | 6058 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 88 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 555 | 0.080 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 280 | 0.080 |
Why?
|
| Lymphatic Metastasis | 4 | 2018 | 425 | 0.080 |
Why?
|
| Actins | 2 | 1990 | 320 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 57 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 274 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 500 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 814 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2010 | 14 | 0.080 |
Why?
|
| Diketopiperazines | 1 | 2010 | 7 | 0.080 |
Why?
|
| COUP Transcription Factor II | 1 | 2010 | 99 | 0.080 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2009 | 2 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2011 | 182 | 0.080 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2001 | 91 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2003 | 300 | 0.080 |
Why?
|
| src-Family Kinases | 1 | 2010 | 93 | 0.080 |
Why?
|
| Antibody Specificity | 5 | 1998 | 164 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2010 | 699 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 226 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 287 | 0.070 |
Why?
|
| Lung | 1 | 2017 | 1531 | 0.070 |
Why?
|
| Autophagy | 1 | 2012 | 416 | 0.070 |
Why?
|
| Endometrium | 3 | 2001 | 287 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 1990 | 174 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 195 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 324 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 335 | 0.070 |
Why?
|
| Time Factors | 4 | 2017 | 6169 | 0.070 |
Why?
|
| Focal Adhesions | 1 | 2008 | 14 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 61 | 0.070 |
Why?
|
| Piperazines | 1 | 2010 | 265 | 0.070 |
Why?
|
| Bone Development | 1 | 2008 | 58 | 0.070 |
Why?
|
| Cytoplasm | 3 | 2010 | 248 | 0.070 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2008 | 52 | 0.070 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2007 | 16 | 0.070 |
Why?
|
| HEK293 Cells | 3 | 2015 | 802 | 0.070 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 2000 | 61 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2022 | 354 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1604 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 4 | 2010 | 631 | 0.060 |
Why?
|
| Chromosome Positioning | 1 | 2006 | 2 | 0.060 |
Why?
|
| Aspergillus nidulans | 2 | 1998 | 27 | 0.060 |
Why?
|
| ErbB Receptors | 2 | 2006 | 285 | 0.060 |
Why?
|
| Carcinoma | 1 | 2008 | 291 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 2014 | 235 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1992 | 252 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 91 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2005 | 130 | 0.060 |
Why?
|
| Acetyltransferases | 2 | 2004 | 74 | 0.050 |
Why?
|
| Antineoplastic Agents | 4 | 2017 | 1814 | 0.050 |
Why?
|
| Genes, erbB | 1 | 2004 | 3 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2010 | 739 | 0.050 |
Why?
|
| G2 Phase | 1 | 2004 | 39 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2018 | 3819 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2014 | 423 | 0.050 |
Why?
|
| RNA | 2 | 2003 | 514 | 0.050 |
Why?
|
| Histone Acetyltransferases | 2 | 2004 | 226 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 63 | 0.050 |
Why?
|
| Microfilament Proteins | 2 | 2017 | 269 | 0.050 |
Why?
|
| Cell Size | 1 | 2004 | 78 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 301 | 0.050 |
Why?
|
| Sheep | 2 | 2001 | 228 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 2001 | 130 | 0.050 |
Why?
|
| Antibodies | 3 | 2004 | 316 | 0.050 |
Why?
|
| Receptors, Androgen | 2 | 2021 | 408 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 253 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2323 | 0.050 |
Why?
|
| Hydrocortisone | 3 | 1992 | 213 | 0.050 |
Why?
|
| Lymphoma | 3 | 1991 | 327 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2000 | 140 | 0.050 |
Why?
|
| Glycosphingolipids | 2 | 1994 | 12 | 0.050 |
Why?
|
| Fibroblasts | 3 | 2002 | 848 | 0.050 |
Why?
|
| Culture Techniques | 3 | 1999 | 73 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2022 | 77 | 0.050 |
Why?
|
| Uteroglobin | 1 | 2002 | 43 | 0.050 |
Why?
|
| Blotting, Northern | 3 | 2008 | 234 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 344 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2003 | 229 | 0.050 |
Why?
|
| Tretinoin | 1 | 2022 | 94 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 409 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2001 | 688 | 0.040 |
Why?
|
| Microtubule-Organizing Center | 1 | 2001 | 8 | 0.040 |
Why?
|
| Ependyma | 1 | 2001 | 6 | 0.040 |
Why?
|
| Lateral Ventricles | 1 | 2001 | 16 | 0.040 |
Why?
|
| Pleurodeles | 1 | 2001 | 1 | 0.040 |
Why?
|
| Choroid Plexus | 1 | 2001 | 25 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2001 | 110 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 2 | 1992 | 33 | 0.040 |
Why?
|
| Pyrazoles | 2 | 2017 | 350 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 263 | 0.040 |
Why?
|
| Estrus | 1 | 2001 | 10 | 0.040 |
Why?
|
| Neoplasms | 1 | 2016 | 2994 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 248 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2001 | 117 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 2001 | 11 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2001 | 141 | 0.040 |
Why?
|
| Neocortex | 1 | 2001 | 75 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2002 | 174 | 0.040 |
Why?
|
| DNA, Neoplasm | 2 | 1992 | 282 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2004 | 905 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 128 | 0.040 |
Why?
|
| Cell Growth Processes | 2 | 2010 | 62 | 0.040 |
Why?
|
| Apoptosis | 2 | 2017 | 1821 | 0.040 |
Why?
|
| Yeasts | 1 | 2000 | 43 | 0.040 |
Why?
|
| Thymidine Kinase | 1 | 2000 | 90 | 0.040 |
Why?
|
| Leptin | 1 | 2021 | 218 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2001 | 200 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2013 | 632 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 1999 | 33 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2000 | 243 | 0.040 |
Why?
|
| Temperature | 2 | 1997 | 290 | 0.040 |
Why?
|
| Kinetics | 2 | 1995 | 1087 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 560 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 585 | 0.040 |
Why?
|
| Carnitine O-Acetyltransferase | 1 | 2018 | 3 | 0.030 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2018 | 10 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 724 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 242 | 0.030 |
Why?
|
| Osteolysis | 1 | 2017 | 9 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 3 | 1992 | 52 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2003 | 711 | 0.030 |
Why?
|
| Cerebellum | 1 | 2001 | 441 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2001 | 229 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2018 | 105 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2017 | 11 | 0.030 |
Why?
|
| Nuclear Factor 45 Protein | 1 | 2017 | 3 | 0.030 |
Why?
|
| Clone Cells | 1 | 1998 | 152 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 101 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 131 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 637 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2017 | 12 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 39 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 189 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 73 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 89 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2017 | 35 | 0.030 |
Why?
|
| Uterus | 1 | 2001 | 541 | 0.030 |
Why?
|
| Rabbits | 1 | 1998 | 573 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 436 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 4 | 1995 | 1445 | 0.030 |
Why?
|
| Cantharidin | 1 | 2016 | 2 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1997 | 56 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 4646 | 0.030 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2016 | 12 | 0.030 |
Why?
|
| DNA Primers | 3 | 2008 | 599 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 65 | 0.030 |
Why?
|
| Mammals | 1 | 1998 | 253 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 977 | 0.030 |
Why?
|
| Binding Sites, Antibody | 2 | 2013 | 44 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1988 | 73 | 0.030 |
Why?
|
| Biomarkers, Tumor | 2 | 2017 | 1581 | 0.030 |
Why?
|
| Spleen | 2 | 2000 | 258 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 542 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 226 | 0.030 |
Why?
|
| Pregnancy | 4 | 2001 | 7475 | 0.030 |
Why?
|
| Anilides | 1 | 2015 | 52 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 265 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1988 | 295 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 1992 | 49 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2018 | 374 | 0.030 |
Why?
|
| Vanadates | 1 | 1995 | 9 | 0.030 |
Why?
|
| Prolactin Release-Inhibiting Factors | 1 | 1995 | 1 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1995 | 57 | 0.030 |
Why?
|
| Receptors, LHRH | 1 | 1995 | 13 | 0.030 |
Why?
|
| Genistein | 1 | 1995 | 40 | 0.030 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1994 | 4 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 317 | 0.030 |
Why?
|
| Cell Cycle | 2 | 1995 | 593 | 0.030 |
Why?
|
| Isoflavones | 1 | 1995 | 42 | 0.030 |
Why?
|
| Lewis X Antigen | 1 | 1994 | 11 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1995 | 69 | 0.030 |
Why?
|
| Genes, Immediate-Early | 1 | 1994 | 5 | 0.030 |
Why?
|
| Genes, fos | 1 | 1994 | 14 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 410 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2014 | 219 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 256 | 0.030 |
Why?
|
| Genes, myc | 1 | 1994 | 96 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1986 | 330 | 0.030 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1993 | 10 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1993 | 54 | 0.030 |
Why?
|
| Epithelium | 2 | 1999 | 334 | 0.030 |
Why?
|
| Female | 11 | 2014 | 70545 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2013 | 69 | 0.020 |
Why?
|
| Xenopus | 1 | 2013 | 102 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 1994 | 340 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1993 | 277 | 0.020 |
Why?
|
| G(M1) Ganglioside | 1 | 1992 | 10 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1992 | 43 | 0.020 |
Why?
|
| Poly A | 1 | 1992 | 45 | 0.020 |
Why?
|
| Multigene Family | 1 | 1993 | 291 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 525 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 1992 | 45 | 0.020 |
Why?
|
| RNA Splicing | 3 | 1995 | 236 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2003 | 891 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1991 | 25 | 0.020 |
Why?
|
| Motor Neurons | 1 | 1992 | 131 | 0.020 |
Why?
|
| Interferon-Stimulated Gene Factor 3 | 2 | 2002 | 3 | 0.020 |
Why?
|
| Stem Cells | 1 | 1996 | 702 | 0.020 |
Why?
|
| STAT2 Transcription Factor | 2 | 2002 | 5 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1992 | 394 | 0.020 |
Why?
|
| Katanin | 1 | 2011 | 1 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 231 | 0.020 |
Why?
|
| Subcutaneous Tissue | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 587 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2011 | 30 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 32 | 0.020 |
Why?
|
| Oocytes | 1 | 2013 | 283 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 142 | 0.020 |
Why?
|
| Endothelium, Lymphatic | 1 | 2010 | 10 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2010 | 61 | 0.020 |
Why?
|
| DNA Replication | 1 | 1992 | 355 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2010 | 44 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1990 | 40 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2010 | 83 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 223 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 2 | 2003 | 358 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 420 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2010 | 46 | 0.020 |
Why?
|
| Dynactin Complex | 1 | 2009 | 4 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 1990 | 37 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1990 | 207 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 109 | 0.020 |
Why?
|
| Dasatinib | 1 | 2010 | 50 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2009 | 65 | 0.020 |
Why?
|
| CHO Cells | 2 | 2001 | 151 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 229 | 0.020 |
Why?
|
| Integrases | 1 | 2010 | 157 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 1992 | 329 | 0.020 |
Why?
|
| Stereoisomerism | 2 | 2002 | 106 | 0.020 |
Why?
|
| Gene Library | 1 | 1990 | 212 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1992 | 436 | 0.020 |
Why?
|
| Cricetinae | 2 | 2001 | 361 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 329 | 0.020 |
Why?
|
| Point Mutation | 2 | 2003 | 332 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1990 | 187 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 2008 | 55 | 0.020 |
Why?
|
| Bovine papillomavirus 1 | 1 | 1988 | 8 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 716 | 0.020 |
Why?
|
| Models, Genetic | 2 | 1995 | 749 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 117 | 0.020 |
Why?
|
| Injections | 1 | 2008 | 109 | 0.020 |
Why?
|
| Taxoids | 1 | 2008 | 73 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 86 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2008 | 110 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 4699 | 0.020 |
Why?
|
| Culture Media | 1 | 1988 | 169 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4866 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 1229 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2009 | 450 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2008 | 257 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 787 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2008 | 308 | 0.010 |
Why?
|
| Swine | 1 | 2009 | 1183 | 0.010 |
Why?
|
| Moloney murine sarcoma virus | 1 | 1986 | 2 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3422 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1986 | 44 | 0.010 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1986 | 100 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 1988 | 448 | 0.010 |
Why?
|
| Cattle | 1 | 1986 | 500 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1986 | 220 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2008 | 1480 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1986 | 461 | 0.010 |
Why?
|
| Sp2 Transcription Factor | 1 | 2004 | 1 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2004 | 24 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 992 | 0.010 |
Why?
|
| Spodoptera | 1 | 2003 | 28 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1265 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 305 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 222 | 0.010 |
Why?
|
| Stage-Specific Embryonic Antigens | 2 | 1994 | 3 | 0.010 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 2 | 1994 | 13 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2003 | 276 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 146 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2002 | 29 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 159 | 0.010 |
Why?
|
| Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2002 | 1 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 43 | 0.010 |
Why?
|
| Receptors, Estradiol | 1 | 2001 | 3 | 0.010 |
Why?
|
| Respiratory Mucosa | 1 | 2002 | 93 | 0.010 |
Why?
|
| Immunologic Tests | 1 | 2001 | 18 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2001 | 40 | 0.010 |
Why?
|
| Gastrula | 1 | 2001 | 24 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 316 | 0.010 |
Why?
|
| Middle Aged | 3 | 2011 | 28420 | 0.010 |
Why?
|
| Oogenesis | 1 | 2001 | 50 | 0.010 |
Why?
|
| Estrogen Receptor beta | 1 | 2001 | 79 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 126 | 0.010 |
Why?
|
| RNA Probes | 1 | 1999 | 25 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 1999 | 34 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1999 | 144 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 1109 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 137 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12851 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2001 | 423 | 0.010 |
Why?
|
| Receptors, Somatotropin | 1 | 1997 | 10 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2010 | 8602 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 6772 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1996 | 62 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 1996 | 84 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 1997 | 138 | 0.010 |
Why?
|
| Amides | 1 | 1996 | 81 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1996 | 311 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 317 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 253 | 0.010 |
Why?
|
| Water | 1 | 1996 | 185 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1995 | 32 | 0.010 |
Why?
|
| Neuroimmunomodulation | 1 | 1995 | 18 | 0.010 |
Why?
|
| Half-Life | 1 | 1995 | 148 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1995 | 57 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1994 | 19 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1995 | 125 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1994 | 37 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 732 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 552 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 17650 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1992 | 27 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1992 | 132 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 203 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 121 | 0.010 |
Why?
|
| Glycoconjugates | 1 | 1990 | 7 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1994 | 1061 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1990 | 29 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1992 | 582 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 20897 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1992 | 776 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1983 | 181 | 0.000 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1983 | 53 | 0.000 |
Why?
|
| Substrate Specificity | 1 | 1983 | 287 | 0.000 |
Why?
|
| Cell Separation | 1 | 1983 | 218 | 0.000 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1983 | 235 | 0.000 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1983 | 156 | 0.000 |
Why?
|
| Adult | 1 | 1992 | 31115 | 0.000 |
Why?
|